ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 166

Resident Memory T Cells in Human RA Synovium Display Restricted TCR Clones

Margaret Chang1, Anais Levescot 2, Nathan Nelson-Maney 3, Rachel Blaustein 4, Kellen Winden 1, Allyn Morris 4, Spoorthi Balu 4, Alexandra Wactor 4, Kevin Wei 5, Lauren Henderson 6, Rachael Clark 4, Deepak Rao 4, Robert Fuhlbrigge 7 and Peter Nigrovic 8, 1Boston Children's Hospital, Boston, 2Boston, 3, 4Brigham and Women's Hospital, Boston, 5BWH, Boston, 6Boston Children's Hospital, Watertown, Massachusetts, 7University of Colorado, Aurora, 8Boston Children's Hospital, Boston, Massachusetts

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: memory, Rheumatoid arthritis (RA), T cells, tissue

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Saturday, May 2, 2020

Title: Poster Session 3

Session Type: ACR Abstract Session

Session Time: 4:15PM-5:15PM

Background/Purpose: Resident memory T cells (TRM) are site-specific memory T cells that take up long-term residence in peripheral tissues and aid in pathogen defense. Dysregulated TRM cells have also been implicated in autoimmune diseases by driving localized recurrent inflammation. As RA and JIA are characterized by recurrent joint inflammation, we asked whether TRM cells can be identified in human RA synovium.

Methods: Multicolored tyramide-based immunostaining was performed on formalin-fixed paraffin embedded synovium tissue obtained from RA patients. Tissues were stained with antibodies against CD3, CD8, CD4, CD45RO, CD69 and CD103 surface antigens. Nuclei were visualized with DAPI staining. Immunofluorescence was assessed by immunofluorescence microscopy using the Mantra quantitative pathology imaging and analysis platform. TRM cells were identified by their cell surface expression signature. To identify whether T cells in RA synovium shared a transcriptome signature with TRM cells, we utilized 10X Genomics droplet-based single cell RNA sequencing technology to evaluate gene expression of individual T cells. Leukocytes were harvested from disaggregated RA synovial tissue and memory T cells (CD3+CD45RO+) were enriched by FACS sorting prior to 10X sequencing. We utilized immune cell repertoire profiling that integrates a step into the 10X workflow for targeted amplification of full-length VDJ sequences with primers for the T cell receptor constant regions of both alpha and beta chains.

Results: Using Mantra multispectral immunofluorescence imaging, we visualized synovial cells bearing a signature consistent with TRM cells (CD3+CD45RO+CD69+CD103+) in RA synovium. Single-cell RNA sequencing data of memory T cells isolated from RA synovium revealed a subset of cells with a gene expression signature that is consistent with TRM cells. These CD8-expressing cells demonstrated a transcriptome consistent with immune cell activation and chemokine signaling and displayed a restricted TCR expression profile within the top 0.5% of predominant T cell clones.

Conclusion: We identified T cells with a cell surface expression profile consistent with TRM cells in human RA synovium, across multiple donors. Single-cell RNA sequencing showed that a subpopulation of memory T cells isolated from RA synovium have a transcriptomic signature that is consistent with TRM cells identified in other tissues. These cells are restricted in their TCR sequences and represent some of the most abundant T cell clones in RA synovium. They also express genes involved in immune cell activation and recruitment, suggesting an active role in inflammation.


Disclosure: M. Chang, None; A. Levescot, None; N. Nelson-Maney, None; R. Blaustein, None; K. Winden, None; A. Morris, None; S. Balu, None; A. Wactor, None; K. Wei, None; L. Henderson, Sobi, 1, 2, Adaptive Biotechnologies, 1; R. Clark, None; D. Rao, None; R. Fuhlbrigge, None; P. Nigrovic, Novartis, 1, 2, BMS, 1, 2, Pfizer, 1, 2, Sobi, 1, Miach Orthopedics, 1, Simcere, 1, XBiotech, 1, Quench Bio, 1, UpTiDate, 1, The American Academy of Pediatrics, 1, CARRA, 1.

To cite this abstract in AMA style:

Chang M, Levescot A, Nelson-Maney N, Blaustein R, Winden K, Morris A, Balu S, Wactor A, Wei K, Henderson L, Clark R, Rao D, Fuhlbrigge R, Nigrovic P. Resident Memory T Cells in Human RA Synovium Display Restricted TCR Clones [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/resident-memory-t-cells-in-human-ra-synovium-display-restricted-tcr-clones/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/resident-memory-t-cells-in-human-ra-synovium-display-restricted-tcr-clones/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology